Eagle Pharmaceuticals, Inc.

The momentum for this stock is not very good. Eagle Pharmaceuticals, Inc. is not a good growth stock. Eagle Pharmaceuticals, Inc. is not very popular among insiders. Eagle Pharmaceuticals, Inc. may fit well in a Validea momentum strategy portfolio. Eagle Pharmaceuticals, Inc. is a mediocre stock to choose.

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include ar...

News

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com

Zolmax Equities researchers at StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX - Get Free Report) in a report released on Tuesday. The firm set a "hold" rating on the...\n more…

StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX)

Ticker Report Equities researchers at StockNews.com began coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX - Get Free Report) in a research report issued on Tuesday. The brokerage set a "hold" rating on...\n more…

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX - Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the specialty...\n more…

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com

Zolmax Analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX - Get Free Report) in a report released on Monday. The brokerage set a "hold" rating on the specialty...\n more…

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Short Interest Update

Ticker Report Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX - Get Free Report) saw a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 484,200 shares, a...\n more…

Eagle Pharmaceuticals Struggles with Financial Compliance and Nasdaq Listing

TipRanks Financial Blog Eagle Pharmaceuticals (EGRX) has issued an announcement. Eagle Pharmaceuticals, Inc. is navigating through complex financial challenges, including amendments to its...\n more…